Attached files

file filename
EX-31.1 - CERTIFICATION - Yew Bio-Pharm Group, Inc.f10k2016ex31i_yewbiopharm.htm
10-K - ANNUAL REPORT - Yew Bio-Pharm Group, Inc.f10k2016_yewbiopharm.htm
EX-31.2 - CERTIFICATION - Yew Bio-Pharm Group, Inc.f10k2016ex31ii_yewbiopharm.htm
EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - Yew Bio-Pharm Group, Inc.f10k2016ex21i_yewbiopharm.htm

Exhibit 32

 

Certification of Periodic Financial Report by the Chief Executive Officer and

Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

Solely for the purposes of complying with 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, we, the undersigned Chief Executive Officer and Chief Financial Officer of Yew Bio-Pharm Group, Inc. (the “Company”), hereby certify, based on our knowledge, that the Annual Report on Form 10-K of the Company for the year ended December 31, 2015 (the “Report”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: March 31, 2017 /s/ ZHIGUO WANG
 

Zhiguo Wang

Chief Executive Officer

   
Date : March 31, 2017 /s/ ZHIGUO WANG
 

Zhiguo Wang

Chief Financial Officer